Stanford University, U.S.
Researchers' findings from Stanford University, U.S. advance research
Published in Pharma Investments, Ventures and Law Weekly, November 5th, 2006
This trend article about Stanford University, U.S. is an immediate alert from LawRx to identify developing directions of research.
Study 1: Erythropoietin (Epo) levels rise when vascular endothelial growth factor (VEGF) is blocked.
"VEGF exerts crucial functions during pathological angiogenesis and normal physiology. We observed increased hematocrit (60-75%) after high-grade inhibition of VEGF by diverse methods, including adenoviral expression of soluble VEGF receptor (VEGFR) ectodomains, recombinant VEGF Trap protein and the VEGFR2-selective antibody DC101,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Accentia Biopharmaceuticals
Accentia enters into definitive deal for a $25 million financing - Acorda Therapeutics
Acorda Therapeutics announces $31.5 million financing - Affinergy
Affinergy awarded $1.8 million grant for implant coatings - Aida Pharmaceuticals
Aida Pharmaceuticals' trial genetic cancer treatment awarded prize in China - Arrow International
Arrow International reports 13% increase in sales - Auriga Laboratories
Auriga reports revenue guidance forecast of $26.4 million - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
